Clinical trial
Pulsatile Perfusion Therapy Phase II: A Novel Approach for Improving Cerebral Tissue Blood Flow and Oxygenation
NCT05983744 is registered in ClinicalTrials.gov with Caroline Rickards as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pulsatile Perfusion Therapy Phase II: A Novel Approach for Improving Cerebral Tissue Blood Flow and Oxygenation
- Lead sponsor
- Caroline Rickards
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 27, 2020
- Completion date
- December 17, 2021
- Enrollment
- 21 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.